Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The Europe bone cement market attained a value of USD 209.82 million in 2022. The market is expected to grow at a CAGR of 5.7% between 2023 and 2028 to reach a value of USD 292.55 million by 2028.
Bone cement is defined as a component used as a filler or fixer of bone when a patient suffers from fracture or some kind bone injury. Bone cement can be adhered inside a body in its powdered or liquid form and can last up to 15 to 20 years.
By product, the market can be segmented into calcium phosphate cement (CPC), glass polyalkenoate cement, and polymethyl methacrylate (PMMA) cement. Based on application, the market can be classified into kyphoplasty, arthroplasty, and vertebroplasty. The major end uses of the market include hospitals, ambulatory surgical centres, and clinics. The market can be divided on the basis of country into United Kingdom, Germany, France, and Italy, among others.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the Europe bone cement market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
The calcium phosphate cement (CPC) segment, based on product, holds a significant share in the Europe bone cement market. Calcium phosphate bone cement can penetrate through the bone by being injected during the process of surgery, which makes this process minimally invasive. In this regard, the increasing awareness and inclination towards minimally invasive surgical procedures among the patients are driving the segment’s growth.
Calcium phosphate cement (CPC) is a highly recommended compound to treat bone fracture due to its self-setting properties, osteoconductivity, easy mouldability, and excellent biocompatibility. Meanwhile, the heightened application of polymethyl methacrylate (PMMA) cement in vertebroplasty and arthroplasty is further fuelling the growth of the Europe market for bone cement.
The kyphoplasty segment, based on application, accounts for a healthy share of the market. This process aims at improving spine health and provides comfort to patients suffering from spinal injuries. The increasing prevalence of traumatic spinal cord injuries induced by transport related accidents across countries like Spain and Germany is propelling the demand for bone cement to facilitate kyphoplasty.
In addition, the increasing geriatric population in the region is further fuelling the cases of bone injuries, leading to a greater growth of the Europe bone cement market. Moreover, the increasing complaints of joint pain and fractures, owing to the increasing inclination towards adventure and sports, is expected to boost the demand for bone cement in arthroplasty and vertebroplasty.
Medtronic plc, is a leading medical device manufacturing company based in the United States. The company was founded in the year 1949 and is currently headquartered in Minnesota. Medtronic plc has several subsidiaries which are dedicated towards catering to the healthcare industry around the world. These subsidiaries include Mazor Robotics, Affera, Inc., and Given Imaging, among others.
Arthrex, Inc. is a prominent MedTech company which is dedicated towards producing products in the field of orthopaedics. This company is also a pioneer in the field of arthroscopy and has innovated ground-breaking products. Arthrex, Inc. was founded in the year 1981 and is headquartered in Florida, United States.
Cardinal Health, Inc. is a leading MedTech company headquartered in Ohio, United States, with an estimated workforce of around 48,000. This company innovates diverse solutions and programmes to cater to the needs of healthcare units, pharmacies, physician offices, and clinics. Cardinal Health, Inc. is also investing and innovating with data-driven insights.
Other market players include Johnson & Johnson MedTech (Depuy Synthes), Stryker Corporation, Zimmer Biomet Holdings, Inc, Smith & Nephew plc, Heraeus Medical LLC, Teknimed, and LABORATORIOS SL S.A., among others.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product||
|Breakup by Application||
|Breakup by End Use||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Industry Opportunities and Challenges
8 Europe Bone Cement Market Analysis
8.1 Key Industry Highlights
8.2 Europe Bone Cement Historical Market (2018-2022)
8.3 Europe Bone Cement Market Forecast (2023-2028)
8.4 Europe Bone Cement Market by Product
8.4.1 Calcium Phosphate Cement (CPC)
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2018-2022)
184.108.40.206 Forecast Trend (2023-2028)
8.4.2 Glass Polyalkenoate Cement
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2018-2022)
22.214.171.124 Forecast Trend (2023-2028)
8.4.3 Polymethyl Methacrylate (PMMA) Cement
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2018-2022)
184.108.40.206 Forecast Trend (2023-2028)
8.5 Europe Bone Cement Market by Application
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2018-2022)
22.214.171.124 Forecast Trend (2023-2028)
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2018-2022)
184.108.40.206 Forecast Trend (2023-2028)
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2018-2022)
22.214.171.124 Forecast Trend (2023-2028)
8.6 Europe Bone Cement Market by End Use
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2018-2022)
184.108.40.206 Forecast Trend (2023-2028)
8.6.2 Ambulatory Surgical Centres
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2018-2022)
22.214.171.124 Forecast Trend (2023-2028)
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2018-2022)
184.108.40.206 Forecast Trend (2023-2028)
8.7 Europe Bone Cement Market by Country
8.7.1 Market Share
220.127.116.11 United Kingdom
9 Regional Analysis
9.1 United Kingdom
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Product
9.1.4 Breakup by Application
9.1.5 Breakup by End Use
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Product
9.2.4 Breakup by Application
9.2.5 Breakup by End Use
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Product
9.3.4 Breakup by Application
9.3.5 Breakup by End Use
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Johnson & Johnson MedTech (Depuy Synthes)
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
12.2.2 Stryker Corporation
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
12.2.3 Zimmer Biomet Holdings, Inc
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
12.2.4 Smith & Nephew plc
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
12.2.5 Medtronic plc
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
12.2.6 Arthrex, Inc.
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
12.2.7 Cardinal Health, Inc.
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
12.2.8 Heraeus Medical LLC
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
12.2.10 LABORATORIOS SL S.A.
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
13 Key Trends and Developments in the Market
List of Figures and Tables
1. Europe Bone Cement Market: Key Industry Highlights, 2018 and 2028
2. Europe Bone Cement Historical Market: Breakup by Product (USD Million), 2018-2022
3. Europe Bone Cement Market Forecast: Breakup by Product (USD Million), 2023-2028
4. Europe Bone Cement Historical Market: Breakup by Application (USD Million), 2018-2022
5. Europe Bone Cement Market Forecast: Breakup by Application (USD Million), 2023-2028
6. Europe Bone Cement Historical Market: Breakup by Country (USD Million), 2018-2022
7. Europe Bone Cement Market Forecast: Breakup by Country (USD Million), 2023-2028
8. Europe Bone Cement Market Structure
The market attained a value of USD 209.82 million in 2022.
The market is expected to grow at a CAGR of 5.7% in the forecast period of 2023 to 2028.
The increasing prevalence of skeletal injuries, growing geriatric population, rising healthcare awareness, are the major market drivers of the Europe bone cement market.
The key trends in the market include the technical innovations and upgradations to facilitate the development of minimally invasive bone treatment procedures and busy and hectic lifestyles led by the working population.
Calcium phosphate cement (CPC), glass polyalkenoate cement, and polymethyl methacrylate (PMMA) cement are the different products of bone cement.
Kyphoplasty, arthroplasty, and vertebroplasty are the major applications of bone cement.
Bone cement is used in the repair of skeletal structures, improving the mobility of patients suffering from severe injury or fracture.
Bone cements form a strong bond and exhibit great elasticity and plasticity which bolster their safety, however, some bone cements can fail to produce a strong bond which may lead to injuries.
United Kingdom, Germany, France, and Italy, among others, are the major countries in the Europe markets for bone cement.
Johnson & Johnson MedTech (Depuy Synthes), Stryker Corporation, Zimmer Biomet Holdings, Inc, Smith & Nephew plc, Medtronic plc, Arthrex, Inc., Cardinal Health, Inc., Heraeus Medical LLC, Teknimed, and LABORATORIOS SL S.A., among others, are the key market players, according to the report.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.